{
  "diagnoses": [
    {
      "diagnosis": "Community-acquired pneumonia (CAP) with features of COPD exacerbation",
      "confidence": "high",
      "source": "NICE NG114 (Chronic obstructive pulmonary disease acute exacerbation: antimicrobial prescribing) and NICE ES37 (Antimicrobial prescribing: delafloxacin for community-acquired pneumonia)",
      "url": "https://www.nice.org.uk/guidance/ng114",
      "primary_care": {
        "medications": [
          {
            "drug_name": "Amoxicillin",
            "variations": [
              "Amoxicillin",
              "Amoxicillin trihydrate",
              "Amoxicillin sodium"
            ]
          },
          {
            "drug_name": "Doxycycline",
            "variations": [
              "Doxycycline",
              "Doxycycline hyclate",
              "Doxycycline monohydrate"
            ]
          },
          {
            "drug_name": "Clarithromycin",
            "variations": [
              "Clarithromycin"
            ]
          },
          {
            "drug_name": "Paracetamol",
            "variations": [
              "Paracetamol",
              "Acetaminophen"
            ]
          },
          {
            "drug_name": "Ibuprofen",
            "variations": [
              "Ibuprofen"
            ]
          },
          {
            "drug_name": "Salbutamol",
            "variations": [
              "Salbutamol",
              "Albuterol",
              "Salbutamol sulfate"
            ]
          }
        ],
        "supportive_care": [
          "Oxygen therapy to maintain SpO2 >90%",
          "Adequate hydration and fluid intake",
          "Bed rest during acute phase",
          "Chest physiotherapy to assist sputum clearance",
          "Breathing exercises (pursed-lip breathing)",
          "Monitor and record vital signs including SpO2, RR, temperature"
        ],
        "clinical_guidance": "CURB-65 score of 2 indicates low-intermediate risk but patient requires hospital assessment given SpO2 92%, RR 26, fever 38.8\u00b0C, and pleuritic chest pain. For antibiotic selection: Consider amoxicillin 500mg three times daily for 5-7 days (standard CAP), or doxycycline 100mg twice daily, or clarithromycin if allergy to beta-lactams. Continue existing COPD medications (Tiotropium). Ensure diabetes management continues (Metformin monitoring). Monitor fever, sputum characteristics, respiratory status hourly initially.",
        "when_to_escalate": [
          "SpO2 persistently <90% despite oxygen therapy",
          "Respiratory rate >30 breaths per minute",
          "Systolic BP <90 mmHg or signs of hypotension",
          "Confusion or altered mental status",
          "Severe chest pain or signs of pleural effusion",
          "No clinical improvement after 48 hours of antibiotics",
          "Worsening breathlessness",
          "Coughing up blood (haemoptysis)",
          "Signs of sepsis (tachycardia >120, fever, tachypnoea)",
          "Acute kidney injury or urine output concerns"
        ]
      },
      "diagnostics": {
        "required": [
          "Chest X-ray (PA and lateral) - to confirm pneumonia, assess extent, and exclude complications",
          "Full blood count (FBC) - assess white cell count, infection severity",
          "Urea and electrolytes - assess renal function (completes CURB-65 assessment)",
          "C-reactive protein (CRP) or procalcitonin - assess inflammatory response",
          "Blood cultures (if hospitalized) - identify causative organism",
          "Sputum culture and microscopy - guide antibiotic selection",
          "Arterial or venous blood gas - assess oxygenation and CO2 retention (important in COPD)",
          "ECG - assess for cardiac complications given age and comorbidities"
        ],
        "monitoring": [
          "SpO2 continuous monitoring - target >90%",
          "Daily temperature recordings",
          "Respiratory rate monitoring - expect to trend downward with treatment",
          "Sputum colour and volume - expect clearing within 48-72 hours",
          "Repeat chest X-ray at 4-6 weeks if consolidation present (to exclude malignancy in smokers)"
        ],
        "referral_criteria": [
          "Referral to hospital medicine/respiratory specialist if deterioration despite antibiotics",
          "Intensive care referral if respiratory failure develops (SpO2 <90% despite oxygen, RR >30, CO2 retention)",
          "Infectious disease consultation if atypical organisms suspected or immunocompromised",
          "Consider pulmonology review for COPD optimization given recurrent infections"
        ]
      },
      "follow_up": {
        "timeframe": "Review at 48-72 hours to assess treatment response. If hospitalized, daily assessment. Community follow-up at 1 week post-discharge.",
        "monitoring": [
          "Clinical improvement in cough, sputum production, fever, breathlessness",
          "Vital sign normalization (fever resolution, respiratory rate reduction to <20)",
          "SpO2 improvement to baseline or >94%",
          "Chest auscultation findings - crackles should resolve within 48-72 hours",
          "Symptom severity using CAP severity scales",
          "Tolerance of oral intake and hydration status",
          "Blood glucose management in view of infection stress (diabetes comorbidity)"
        ],
        "referral_criteria": [
          "No improvement or worsening within 48-72 hours despite appropriate antibiotics - consider changing antibiotic class or investigating for complications (pleural effusion, empyema, sepsis)",
          "Development of complications - refer to hospital immediately",
          "Severe immunosuppression or atypical presentation - specialist review needed",
          "After recovery: Consider COPD action plan review and pulmonary rehabilitation referral"
        ]
      }
    }
  ],
  "summary": "\nCLINICAL ANALYSIS REPORT\n\nDIAGNOSES (1):\n\n- Community-acquired pneumonia (CAP) with features of COPD exacerbation (high confidence)",
  "bnf_prescribing_guidance": []
}